Tejara Capital’s ARS Pharmaceuticals SPRY Stock Holding History

Tejara Capital’s Portfolio SPRY Stock Details SPRY Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.69M	Buy
2024 Q1	–	Sell
2023 Q4	$404K	Sell
2023 Q3	$392K	Sell
2023 Q2	$895K	Sell
2023 Q1	$1.35M	Buy
2022 Q4	$296K	Buy